Intrauterine Devices Market Set to Reach $4.4 Billion by 2031 | CAGR of 3.8%

The global intrauterine devices (IUDs) market is poised for substantial growth, with projections indicating a rise from $3.0 billion in 2021 to $4.4 billion by 2031, representing a CAGR of 3.8% from 2022 to 2031. Intrauterine devices, also known as intrauterine contraceptive devices, are T-shaped birth control devices inserted into the uterus to prevent pregnancy by altering the movement of sperm toward the egg. They are considered a safe and effective form of long-acting reversible birth control, suitable for adolescents and nulliparous women.


𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.alliedmarketresearch.com/request-sample/A10999

The market is segmented into two types based on hormone release ability: non-hormonal (copper-containing IUD) and hormonal (progestogen-releasing IUD). The copper-containing IUD, in particular, is utilized as an emergency contraceptive within five days after unprotected intercourse, offering 99% effectiveness against pregnancy.

The Intrauterine Devices Market Trends that drive the growth of the market are an increase in focus on family planning, health issues associated with teenage pregnancies, increase in awareness about hormonal uterine device methods, which are key methods to prevent unplanned pregnancy. Advancing intrauterine hormonal devices with better efficacy and fewer side effects further boost market growth. However, the availability of alternate contraceptive methods, health risks associated with the use of hormonal intrauterine devices, and lack of social acceptance adversely affect the market growth.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐟𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬:

➤ Quantitative analysis of market segments, current trends, estimations, and dynamics from 2021 to 2031 to identify prevailing opportunities.

➤ Insights into key drivers, restraints, and opportunities, aiding profit-oriented business decisions.

➤ Porter's five forces analysis assessing the potency of buyers and suppliers, facilitating informed decisions and strengthening supplier-buyer networks.

➤ In-depth segmentation analysis to determine market opportunities.

➤ Mapping of major countries according to their revenue contribution to the global market.

➤ Market player positioning for benchmarking and a clear understanding of market player standings.

➤ Analysis of regional and global trends, key players, market segments, application areas, and growth strategies.


𝐄𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A10999

𝐈𝐧𝐭𝐫𝐚𝐮𝐭𝐞𝐫𝐢𝐧𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬:

𝐓𝐲𝐩𝐞:
● Nonhormonal: Copper-containing IUD

● Hormonal: Progestogen-releasing IUD

𝐀𝐠𝐞 𝐆𝐫𝐨𝐮𝐩:

● 25-34 years

● 35-44 years

● Above 44 years

● 15-24 years

𝐄𝐧𝐝 𝐔𝐬𝐞𝐫:

● Hospitals

● Clinics

● Community Health Care Centres

● Others

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

● Pregna International Limited

● Mona Lisa NV

● Viatris Inc

● CooperSurgical Inc

● DKT International

● Bayer AG

● Prosan International BV

● Abviee Inc

● Eurogine, S.L.

● Other Players:

● Stryker Corporation

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.